Investment Analysts’ Weekly Ratings Updates for Cigna Group (CI)

A number of research firms have changed their ratings and price targets for Cigna Group (NYSE: CI):

  • 11/19/2026 – Cigna Group had its price target raised by Royal Bank Of Canada from $337.00 to $346.00. They now have an “outperform” rating on the stock.
  • 11/13/2026 – Cigna Group had its price target raised by Wells Fargo & Company from $307.00 to $325.00. They now have an “equal weight” rating on the stock.
  • 11/12/2026 – Cigna Group had its price target raised by Jefferies Financial Group from $288.00 to $304.00. They now have a “hold” rating on the stock.
  • 11/12/2026 – Cigna Group had its price target lowered by Piper Sandler from $370.00 to $360.00. They now have an “overweight” rating on the stock.
  • 11/11/2026 – Cigna Group had its price target raised by Sanford C. Bernstein from $387.00 to $390.00. They now have an “outperform” rating on the stock.
  • 11/11/2026 – Cigna Group was given a new $390.00 price target by Wells Fargo & Company.
  • 11/9/2026 – Cigna Group had its price target raised by Barclays from $310.00 to $320.00. They now have an “equal weight” rating on the stock.
  • 11/8/2026 – Cigna Group was upgraded by Wall Street Zen from “hold” to “buy”.
  • 11/6/2026 – Cigna Group had its price target lowered by Guggenheim from $361.00 to $347.00. They now have a “buy” rating on the stock.
  • 11/6/2026 – Cigna Group had its “overweight” rating reaffirmed by Cantor Fitzgerald. They now have a $340.00 price target on the stock.
  • 10/31/2026 – Cigna Group was downgraded by Wall Street Zen from “buy” to “hold”.
  • 10/23/2026 – Cigna Group had its “overweight” rating reaffirmed by Piper Sandler.
  • 10/2/2026 – Cigna Group had its “outperform” rating reaffirmed by Sanford C. Bernstein.
  • 10/2/2026 – Cigna Group was given a new $370.00 price target by Piper Sandler. They now have an “overweight” rating on the stock.
  • 10/2/2026 – Cigna Group had its price target raised by Piper Sandler from $346.00 to $370.00. They now have an “overweight” rating on the stock.
  • 10/1/2026 – Cigna Group had its “buy” rating reaffirmed by UBS Group.
  • 10/1/2026 – Cigna Group had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $337.00 price target on the stock.
  • 9/26/2026 – Cigna Group was upgraded by Wall Street Zen from “hold” to “buy”.

Cigna Group Stock Performance

Shares of NYSE CI traded down $12.21 during trading on Thursday, reaching $273.17. The stock had a trading volume of 3,650,314 shares, compared to its average volume of 1,683,552. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The stock has a market cap of $71.98 billion, a PE ratio of 12.05, a P/E/G ratio of 1.10 and a beta of 0.25. Cigna Group has a one year low of $257.85 and a one year high of $318.05. The firm’s 50 day moving average price is $288.37 and its two-hundred day moving average price is $283.00.

Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. The firm had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. Cigna Group’s revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the business posted $7.83 EPS. On average, research analysts forecast that Cigna Group will post 30.71 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s payout ratio is presently 27.54%.

Insiders Place Their Bets

In other news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

Further Reading

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.